Inflammation of bronchial smooth muscle in allergic asthma.

Publié en January 2007

Omalizumab decreases nonspecific airway hyperresponsiveness in vitro.

Previous publication

Chymase-positive mast cells: a double-edged sword in asthma?

Next publication

Authors

Begueret H
Berger P
Vernejoux JM
Dubuisson L
Marthan R
Tunon-de-Lara JM